Use and application of stem cells in toxicology

Toxicological Sciences

Volumn 79, Issue 2, 2004, Pages 214-223

  Davila, Julio C ^a   Cezar, Gabriela G ^b   Thiede, Mark ^a   Strom, Stephen ^c   Miki, Toshio ^c   Trosko, James ^d  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^b Department of Pathology ^*

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPHENOTANE; GOSSYPOL DERIVATIVE; NEW DRUG; PHENOBARBITAL; PHTHALIC ACID DERIVATIVE; THALIDOMIDE;

BIOMEDICINE; BLOOD VESSEL; BONE MARROW CELL; CARDIOTOXICITY; CELL CULTURE; CELL DIFFERENTIATION; CELL RENEWAL; DRUG SYNTHESIS; EMBRYO CELL; EPIGENETICS; GENETIC SELECTION; GENOTOXICITY; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL; HUMAN; IN VITRO STUDY; LIVER CELL; LIVER TOXICITY; NERVE CELL; NONHUMAN; PANCREAS ISLET CELL; PLACENTA; PREDICTION; QT PROLONGATION; REPRODUCTIVE TOXICITY; REVIEW; STEM CELL; TOXICITY TESTING; TOXICOLOGY;

EID: 2942754297     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/kfh100     Document Type: Review

References (68)

1. Alison, M. R., Poulsom, R., Jeffery, R., Dhillon, A. P., Quaglia, A., Jacob, J. Novelli, M., Prentice, G., Williamsom, J., and Wright, N. A. (2000). Hepatocytes from nonhepatic adult stem cells. Nature 406, 257-258.
2. Alvarez-Dolado, M., Pardal, R., Garcia-Verdugo, J. M., Fike, J. R., Lee, H. O., Pfeffer, K., Lois, C., Morrison, S. J., and Alvarez-Buylla, A. (2003). Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425, 968-973.
3. Billon, N., Jolicoeur, C., Ying, Q. L., Smith, A., and Raff, M. (2002). Normal timing of oligodendrocyte development from genetically engineered, lineage-selectable mouse ES cells. J. Cell Sci. 115, 3657-3665.
4. Bird, S. D., Doevendans, P. A., van Rooijen, M. A., Riviere, A. B., Hassink, R. J., Passier R., and Mummery, C. (2003). The human adult cardiomyocyte phenotype. Cardiovasc. Res. 58, 423-434.
5. Chambers, I., Colby, D., Robertson, M., Nichols, J., Lee, S., Tweedie, S., and Smith, A. (2003). Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113, 643-655.
6. Choi, D., Oh, H. J., Chang, U. J., Koo, S. K., Jiang, J. X., Hwang, S. Y., Lee, J. D., Yeoh, G. C., Shin, H. S., Lee, J. S., and Oh, B. (2002). In vitro differentiation of mouse embryonic stem cells into hepatocytes. Cell Transplant. 11, 359-368.
7. Chung, S., Sonntag, K., Andersson, T., Bjorklund, L. M., Park, J., Kim, D., Kang, U., Isacson, O., and Kim, K. (2002). Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons. Eur. J. Neurosci. 16, 1829-1838.
8. Clarke, D. L., Johansson, C. B., Wilbertz, J., Veress, B., Nilsson, E., Karlstrom, H., Lendahl, U., and Frisen, J. (2000). Generalized potential of adult neural stem cells. Science, 288, 1660-1663.
9. Cubeddu, L. X. (2003). QT prolongation and fatal arrhythmias: a review of clinical applications and effects of drugs. Am. J. Ther. 10, 452-457.
10. Eiges R., Schuldiner, M., and Drukker, M. (2001). Establishment of human embryonic stem cell-transfected clones carrying a marker for undifferentiated cells. Curr. Biol. 11, 514-518.
11. Genschow, E., Scholz, G., Brown, N., Piersma, A., Brady, M., Clemann, N., Huuskonen, H., Paillard, F., Bremer, S., Becker, K., and Spielmann, H. (2000). Development of prediction models for three in vitro embryotoxicity tests in an ECVAM validation study. In Vitro Mol. Tox. 13, 51-65.
12. Gorba, T., and Allsopp, T. E. (2003). Pharmacological potential of embryonic stem cells. Pharmacol. Res. 47, 269-278.
13. He, J. Q., Ma, Y., Lee, Y., Thompson, J. A., and Kamp, T. (2003). Human embryonic stem cells develop into multiple types of cardiac myocytes: Action potential characterization. Circ. Res. 93, 1-9.
14. Hidaka, K., Lee, J., Kim, H. S., Ihm, C. H., Ilio, A., Ogawa, M., Nishikawa, S., Kodama, I., and Morisaki, T. (2003). Chamber-specific differentiation of Nkx2.5-positive cardiac precursor cells from murine embryonic stem cells. FASEB J.
15. Hubner, K., Fuhrmann, G, Christenson, L. K., Kehler, J., Reinbold, R., De La Fuente, R., Wood, J., Strauss, J. F., III, Boiani, M., and Scholer, H. R. (2003). Derivation of oocytes from mouse embryonic stem cells. Science 300, 1251-1256.
16. Ishizaka, S., Shiroi A, Kanda, S., Yoshikawa, M., Tsujinoue, H., Kuriyama, S., Hasuma, T., Nakatani, and K., Takahashi, K. (2002). Development of hepatocytes from ES cells after transfection with the HNF-3β gene. FASEB J. 16, 1444-1446.
17. Jackson, K. A, Mi, T., and Goodell, M. A. (1999). Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc. Natl. Acad. Sci. U S A 96, 14482-14486.
18. Jiang, Y., Jahagirdar, B. N., Reinhardt, R. L., Schwartz, R. E., Keene, C. D., Ortiz-Gonzalez, X. R., Reyes, M., Lenvik, T., Lund, T., Blackstad, M., Du, J., Aldrich, S., Lisberg, A., Low, W. C., Largaespada, D. A., and Verfaillie, C. M. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41-49.
19. Jones, E. A., Tosh, D., Wilson, D. I., Lindsya, S., And Forrester, L. M. (2002). Hepatic differentiation of murine embryonic stem cells. Exp. Cell. Res. 272, 15-22.
20. Kehat, I., Gepstein, A., Spira, A., Iskovitz-Eldor, J., and Gepstein, L. (2002). High-resolution electrophysiological assessment of human embryonic stem cell-derived cardiomyocytes. Circ. Res. 91, 659-661.
21. Kehat, I., Kenyagin-Karsenti, D., Snir, M., Segev, H., Amit, M., Gepstein, A. S., Livne, E., Binah, O., Itskovitz-Eldor, J., and Gepstein, L. (2001). Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest. 108, 407-414.
22. Kim, J. H., Auerbach, J. M., Rodriguez-Gomez, J. A., Velasco, I., Gavin, D., Lumelsky, N., and McKay, R. (2002). Dopamine neurons derived from embryonic stem cells function in animal models of Parkinson's disease. Nature 418, 50-56.
23. King, T. J., Fukushima, L. H., Donlon, T. A., Hieber, A. D., Shimabukukuro, K. A., and Bertram, J. S. (2000). Correlation between growth control, neoplastic potential., and endogenous connexin43 expression in Hela cell lines: Implications for tumor progression. Carcinogenesis 21, 311-315.
24. Klug, M. G., Soonpaa, M. H., Koh, G. Y., and Field, L. J. (1996). Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J. Clin. Invest. 98, 216-224.
25. Kuehl, P., Zang, J., Lin, Y., Lamba, J., Assen, M., Schuetz, J., Watkins, P., Daly, A., Wrighton, S., Hall, S, Maurel, P., Relling, M., Brimer, C., Yasuda, K., Venkataramanan, R., Strom, S., Thummel, K., Bogsuki, M. S., and Schuetz, E. (2001). Sequence diversity in CYP3A promoters and characterization of the genetic basis for polymorphic CYP3A5 expression. Nat. Genet. 4, 383-391.
26. Lamba, J., Lin, Y., Thummel, K., Daly, A., Watkins, P., Strom, S., Zang, J., and Schuetz, E. (2002). Common allelic variants of cytochrome P4503A4 and their prevalence in different populations. Pharmacogenetics 12, 1-12.
27. Lavon, N., and Bevenisty, N. (2003). Differentiation and genetic manipulation of human embryonic stem cells and the analysis of the cardiovascular system. Trends Cardiovasc. Med. 13, 47-52.
28. Lo, C. W. (1996). The role of gap junction membrane channels in development. J. Bioenerg. Biomembr. 28, 379-385.
29. Makino, S., Fukuda, K., Miyoshi, S., Konishi, F., Kodama, H., Pan, J., Sano, M., Takahashi, T., Hori, S., Abe, H., Hata, J., Umezawa, A., and Ogawa, S. (1999). Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 103, 697-705.
30. Martin, G. R. (1981). Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. U S A 78, 7634-7638.
31. Miki, T., Cai, H., Lehmann, T. L., and Strom, S. C. (2002). Production of hepatocytes from human amniotic stem cells. Hepatology 36, 171A (Abstract).
32. Morganroth, J. (1993). Relations of QTc prolongation on the electrocardiogram to torsade de pointes: definitions and mechanisms. Am. J. Cardiol. 72, 10B-13B.
33. Muller, M., Fleischmann, B. K., Selbert, S., Ji, G. J., Endl, E., Middeler, G., Muller, O. J., Schlenke, P., Frese, S., Wobus, A. M., Hescheler, J., Katus, H. A., and Franz, W. M. (2000). Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB J. 14, 2540-2548.
34. Mummery, C., Ward, D., and van den Brink, C. E. (2002). Cardiomyocyte differentiation of mouse and human embryonic stem cells. J. Anat. 200, 489-493.
35. Nagy, A., Gocza, E., and Diaz, E. M. (1990). Embryonic stem cells alone are able to support fetal development in the mouse. Development 110, 815-821.
36. Newall, D. R., and Beedles, K. E. (1996). The stem cell test: an in vitro assay for teratogenic potential. Results of a blind trial with 25 compounds. Tox. in Vitro 10, 229-240.
37. Niwa, H., Miyazaki, J., and Smith, A. G. (2000). Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation, or self-renewal of ES cells. Nat. Genet. 24, 372-376.
38. Pfeifer, A., Ikawa, M., Dayn, Y., and Verma, I. M. (2002). Transgenesis by lentiviral vectors: Lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos. Proc. Natl. Acad. Sci. USA 99, 2140-2145.
39. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal., R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., and Marshak, D. R. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147.
40. Ramalho-Santos, M., Yoon, S., Matsuzaki, Y., Mulligan, R. C., and Melton, D. A., (2002). "Stemness" transcriptional profiling of embryonic and adult stem cells. Science 298, 597-600.
41. Rambhatla, L., Chiu, C.-P., Kundu, P., Peng., Y, and Carpenter, M. K. (2003). Generation of hepatocyte-like cells from human embryonic stem cells. Cell Transplant. 12, 1-11.
42. Raucy, J., Mueller, L., Duan, K., Allen, S. W., Cai, H., Strom, S., and Lasker, J. (2002). Expression and induction of CYP2C P450 enzymes in primary cultures of human hepatocytes. Drug Metab. Disp. 302, 475-482.
43. Reubinoff, B. E., Pera, M. F., Fong, C. T., Trounson, A., and Bongso, A. (2000). Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro. Nat. Biotechnol. 18, 399-404.
44. Reyes, M., Lund, T., Lenvik, T., Aguiar, D., Koodie, L., and Verfaillie, C. M. (2001). Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98, 2615-2625.
45. Rohwedel, J., Guan, K., Hegert, C., and Wobus, A. M. (2001). Embryonic stem cells as an in vitro model for mutagenicity, cytotoxicity and embryotoxicity studies: present state and future prospects. Tox. in Vitro 15, 741-753
46. Sato, N, Sanjuan, I. M., Heke, M., Uchida, M., Naef, F., and Brivanlou, A. H. (2003). Molecular signature of human embryonic stem cells and its comparison with the mouse. Dev. Biol. 260, 404-413.
47. Scarpelli, D. G., and Rao, M. S. (1981). Differentiation of regenerating pancreatic cells into hepatocyte-like cells. Proc. Natl. Acad. Sci. U S A 78, 2577-2581.
48. Scholz, G., Genschow, E., Pohl, I., Bremer, S., Paparella, M., and Raabe, H. (1999). Prevalidation of the embryonic stem cell test EST - A new in vitro embryotoxicity test. Toxicol. In Vitro 13, 675-681.
49. Schuetz, E. G., Schuetz, J. D., Strom, S. C, Thompson. M. T., Molowa, D. T., Fisher, R. A., Molowa, D. T., Li, D., and Guzelian, P. S. (1993). Regulation of human liver cytochromes P450 in Families 3A in Primary and Continuous Culture of Human Hepatocytes. Hepatology 18, 1254-1262.
50. Schwartz, R. E., Reyes, M., Koodie, L., Jiang, Y., Blackstad, M., Lund, T., Lenvik, T., Johnson, S., Hu, W. S., and Verfaillie, C. M. (2002). Multipotent adult progenitor cells from bone marrow differentitate into functional hepatocyte-likc cells. J. Clin. Invest. 109, 1291-1302.
51. Shake, J. G., Gruber, P. J., Baumgartner, W. A., Senechal, G., Meyers, J., Redmond, J. M., Pittenger, M. F., and Martin, B. J. (2002). Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann. Thorac. Surg. 73, 1919-1925; discussion 1926.
52. Spielmann, H., Genschow, E., Scholz, G., Brown, N. A., Piersma, A. H., Brady, M., Clemann, N., Huuskonen, H., Paillard, F., Bremer, S., and Becker, K. (2001). Preliminary results of the ECVAM validation study in three in vitro embryotoxicity tests. ATLA 29, 301-303.
53. Theise, N. D., and Krause, D. S. (2002). Toward a new paradigm of cell plasticity. Leukemia 16, 542-548.
54. Thomson, J. A., Iskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., and Jones, J. M. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147.
55. Toma, J. G., Akhavan, M., Fernandes, K. J. L., Barnabe-Heider, F., Sadikot, A., Kaplan, D. R., and Miller, F. D. (2001). Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat. Cell Biol. 3, 778-784.
56. Toma, C, Pittenger, M. F., Cahill, K. S., Byrne, B. J., Kessler, P. D. (2002) Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105, 93-98.
57. Trosko, J. E., Chang, C. C., Upham, B., and Wilson, M. (1998a). Epigenetic toxicology as toxicant-induced changes in intracellular signalling leading to altered gap junctional intercellular communication. Toxicol. Lett. 102-103, 71-78.
58. Trosko, J. E. and Ruch, R. J. (1998b). Cell-cell communication in carcinogenesis. Front. Biosci. 3, 208-236.
59. Trosko, J. E., Chang, C. C., Wilson, M. R., Upham, B. L., Hayashi, T., and Wade, M. (2000). Gap junctions and the regulation of cellular function of stem cells during development and differentiation. Methods 20, 245-264.
60. Trosko, J. E. (2003a). Human stem cells as targets for the aging and diseases of aging processes. Med. Hypotheses 60, 439-447.
61. Trosko, J. E. (2003b). The role of stem cells and gap junctional intercellular communication in carcinogenesis. J. Biochem. Mol. Biol. 36, 43-48.
62. Vanparys, P. (2002). ECVAM and pharmaceuticals. (2002). Altern. Lab. Anim.(Suppl. 2), 221-223.
63. Xu, R. H., Chen, X., Li, D. S., Li, R., Addicks, G. C., Glennon, C., Zwaka, T. P., and Thomson, J. A. (2002). BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat. Biotechnol. 201, 1261-1264.
64. Yamada, T., Yoshikawa. M., Kanda, S., Kato, Y., Nakajima, Y., Ishizaka, S., and Tsunoda Y. (2002). In vitro differentiation of embryonic stem cells into hepatocyte-like cells identified by cellular uptake of indocyanine green. Stem Cells 20, 146-154.
65. Yang, L., Li, S., Hatch, H., Ahrens, K., Cornelius, J. G., Petersen, B. E., and Peck, A. B. (2002). In vitro trans-dfferentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc. Natl. Acad. Sci. U S A 99, 8078-8083.
66. Zhao, Y., Glesne, D., and Huberman, E. (2003). A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc. Natl. Acad. Sci. U S A 100, 2426-2431.
67. Zuk, P. A., Zhu, M., Ashjian, P., De Ugarte, D. A., Huang, J. I., Mizuno, H., Alfonso, Z. C., Fraser, J. K., Benhaim, P., and Hedrick, M. H. (2002). Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell. 13, 4279-4295.
68. Zuk, P. A., Zhu, M., Mizuno, H., Huang, J., Futrell, J. W., Katz, A. J., Benhaim, P., Lorenz, H. P., and Hedrick, M. H. (2001). Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng. 7, 211-228.